Travel medicine in a new era One expert examines what questions GPs can expect and the best advice to give.
How AHPRA’s cosmetic reform could impact GPs Cosmetic medicine is about to have a facelift, with major changes looming for the lucrative industry – but will GPs be unfairly targeted?
Opioid treatment study ‘may impact’ future Australian guidelines Results from a clinical trial of extended-release buprenorphine injections reveal high retention and treatment satisfaction.
Free webinar aims to upskill GPs on treating gambling harm SPONSORED: The training will help GPs identify patients with potential gambling issues and provide strategies to minimise harm and aid recovery.
Providing help that is needed but not wanted Dr Thileepan Naren’s choice to persevere with a patient during their recovery from opioid addiction led to triumphant outcomes.
Active Ingredient Prescribing grace period ends 31 July GPs and practices are being reminded to update their prescribing software to ensure legislative requirements are met.
Study reinforces that brief intervention for alcohol use ‘works’ GP referrals help prevent moderate and high-risk alcohol users from returning to hospital, a recent Australian-run trial has found.
Value vs volume Dr Kean Seng Lim joins hosts Charlotte, Ash and Bek to discuss value versus volume, and the asymmetry of benefit.
Rest or exercise following concussion? An updated body of work suggests the latter, building on substantial evidence that bedrest can potentially cause long-term risk.
Lack of awareness key barrier to breast cancer chemoprophylaxis It can reduce the risk of breast cancer by one-third to one-half, yet new research finds 35% of GPs are unaware of chemoprophylaxis.